RIGEL PHARMACEUTICALS INC (RIGL) › RevenueRIGEL PHARMACEUTICALS INC (RIGL) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $20.38M2017: $4.48M2018: $44.51M2019: $59.29M2020: $108.62M2021: $149.24M2022: $120.24M2023: $116.88M2024: $179.28M2025: $294.28M$294.28M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$294.28M+64.1%2024$179.28M+53.4%2023$116.88M-2.8%2022$120.24M-19.4%2021$149.24M+37.4%2020$108.62M+83.2%2019$59.29M+33.2%2018$44.51M+892.6%2017$4.48M-78.0%2016$20.38M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share